CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has
been asked to serve on two Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay Development [2017/01 ZRG1 IMST-L (10)] and Special Emphasis Panel/Scientific Review Group of HIV/AIDS Innovative Research Applications [2017/01 ZRG1-AARR-M (81) meeting].
IMST-L (10)
http://public.csr.nih.gov/StudySections/IntegratedReviewGroups/IMSTIRG/IMST10/Pages/default.aspx
AARR-M
http://public.csr.nih.gov/StudySections/IntegratedReviewGroups/AARRIRG/Pages/default.aspx
